Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma

Authors
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1038%2Fbjc.2014.32...
      Last time updated on 04/12/2019